Publication date: Jun 18, 2024
To investigate the contributors to self-rated health in people with late-stage Parkinson’s disease (PD) and cognitive impairment. A secondary analysis of baseline data from the international Care of Late-Stage Parkinsonism (CLaSP) cohort study was conducted. Participants with PD and either dementia or mild cognitive impairment or MMSE
Open Access PDF
| Concepts | Keywords |
|---|---|
| Clinical | Cognitive impairment |
| Cohort | Parkinson’s disease |
| Dementia | Self-rated health. |
| Late | |
| Parkinsonism |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | cognitive impairment |
| disease | MESH | Parkinson’s disease |
| disease | MESH | Parkinsonism |
| disease | MESH | dementia |
| disease | MESH | caregiver burden |
| disease | MESH | secondary parkinsonism |
| disease | MESH | Marital Status |
| drug | DRUGBANK | Levodopa |
| disease | MESH | complications |
| disease | MESH | functional dependence |
| disease | MESH | clinical importance |
| drug | DRUGBANK | Ademetionine |
| drug | DRUGBANK | Donepezil |
| drug | DRUGBANK | Rivastigmine |
| drug | DRUGBANK | Memantine |
| disease | MESH | Alzheimer’s disease |
| disease | MESH | Psychosis |
| disease | MESH | Neurodegenerative Diseases |
| pathway | REACTOME | Neurodegenerative Diseases |
| drug | DRUGBANK | Etoperidone |
| pathway | KEGG | Parkinson disease |
| drug | DRUGBANK | Trihexyphenidyl |
| drug | DRUGBANK | Profenamine |
| disease | MESH | Movement Disorders |
| drug | DRUGBANK | Dimercaprol |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | emotional distress |
| disease | MESH | morbidity |
| drug | DRUGBANK | Carbidopa |
| drug | DRUGBANK | Diethylstilbestrol |
Original Article
(Visited 6 times, 1 visits today)